<p>Skye Bioscience, Inc.（纳斯达克代码：SKYE - 获取免费报告）的股票在目前覆盖该公司的六家研究机构中获得了平均 “买入” 的推荐，MarketBeat Ratings 报告称。六位投资分析师对该股票给予了买入推荐。在过去一年中，覆盖该股票的经纪人给出的平均一年目标价格为 18.67 美元。</p>
<p>获取 <strong>Skye Bioscience</strong> 的提醒：</p>
<ul>
<li>MarketBeat 周报 – 10/7 - 10/11</li>
</ul>
<p>另外，William Blair 在周五的一份研究报告中开始覆盖 Skye Bioscience 的股票。他们对该公司的评级为 “跑赢大盘”。</p>
<p><strong>查看我们关于 Skye Bioscience 的最新股票报告</strong></p>
<h2>机构投资者对 Skye Bioscience 的看法</h2>
<ul>
<li>不要忽视 Skye Bioscience——这款减肥药可能会飙升</li>
</ul>
<p>机构投资者和对冲基金最近调整了对该股票的持有。Virtu Financial LLC 在第四季度购买了 Skye Bioscience 的新股份，价值约 29,000 美元。Wells Fargo &amp; Company MN 在第四季度将其在 Skye Bioscience 的持仓提高了 49.0%。Wells Fargo &amp; Company MN 现在拥有该公司 11,199 股股票，价值 32,000 美元，此前在此期间又购买了 3,684 股。Two Sigma Advisers LP 在第四季度购买了 Skye Bioscience 的新股份，价值约 32,000 美元。Jane Street Group LLC 在第三季度购买了 Skye Bioscience 的新股份，价值约 48,000 美元。最后，Squarepoint Ops LLC 在第四季度购买了 Skye Bioscience 的新股份，价值约 38,000 美元。21.09% 的股票由对冲基金和其他机构投资者持有。</p>
<h2>Skye Bioscience 价格表现</h2>
<p>周五，SKYE 的股票开盘价为 2.68 美元。该公司的 50 日简单移动平均线为 3.02 美元，200 日简单移动平均线为 3.17 美元。Skye Bioscience 的 12 个月最低价为 2.31 美元，最高价为 19.41 美元。</p>
<h2>关于 Skye Bioscience</h2>
<p>（获取免费报告）</p>
<ul>
<li>3 只高风险、高回报的微型股你不应忽视</li>
</ul>
<p>Skye Bioscience, Inc. 是一家临床阶段的制药公司，发现、开发和商业化基于大麻素的分子用于治疗传染病。该公司的主要产品候选药物是用于治疗青光眼和眼内高压的 SBI-100。它还在开发 SBI-200，以治疗和管理各种眼病，包括葡萄膜炎、干眼症、黄斑变性和糖尿病视网膜病变。</p>
<h2>精选故事</h2>
<ul>
<li>五只我们更看好的股票而非 Skye Bioscience</li>
<li>恒生指数是什么？</li>
<li>3 只值得关注的股票：解锁明天的赢家</li>
<li>股票平均计算器</li>
<li>为什么聪明的投资者在关注这 3 只被低估的股票</li>
<li>顶尖生物科技股票：探索创新机会</li>
<li>3 只突破增长潜力的股票</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9U0tZRQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9U0tZRQ"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Skye Bioscience 吗？</h2>
<p>在你考虑 Skye Bioscience 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Skye Bioscience 并不在名单上。</p>
<p>虽然 Skye Bioscience 目前在分析师中获得了买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

SKYE

<p>Skye Bioscience, Inc.（纳斯达克代码：SKYE）获得了六家研究公司的平均 “买入” 推荐。平均一年目标价为 18.67 美元。最近，William Blair 开始覆盖，并给予 “跑赢大盘” 的评级。机构投资者增加了他们的持股，21.09% 的股票由对冲基金持有。目前，股票交易价格为 2.68 美元，12 个月的价格区间为 2.31 美元至 19.41 美元。Skye Bioscience 专注于基于大麻素的各种眼病治疗，包括青光眼</p>

<p>Shares of Skye Bioscience, Inc. (NASDAQ:SKYE - Get Free Report) have earned an average recommendation of &#34;Buy&#34; from the six research firms that are currently covering the firm, MarketBeat Ratings reports. Six investment analysts have rated the stock with a buy recommendation. The average 1 year price objective among brokers that have covered the stock in the last year is $18.67.</p>
<div class="lb-trans"><p>Skye Bioscience, Inc.（纳斯达克代码：SKYE - 获取免费报告）的股票在目前覆盖该公司的六家研究机构中获得了平均 “买入” 的推荐，MarketBeat Ratings 报告称。六位投资分析师对该股票给予了买入推荐。在过去一年中，覆盖该股票的经纪人给出的平均一年目标价格为 18.67 美元。</p>
</div><p>Get <strong>Skye Bioscience</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Skye Bioscience</strong> 的提醒：</p>
</div><ul>
<li>MarketBeat Week in Review – 10/7 - 10/11</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 周报 – 10/7 - 10/11</li>
</ul>
</div><p>Separately, William Blair started coverage on shares of Skye Bioscience in a research report on Friday. They set an &#34;outperform&#34; rating for the company.</p>
<div class="lb-trans"><p>另外，William Blair 在周五的一份研究报告中开始覆盖 Skye Bioscience 的股票。他们对该公司的评级为 “跑赢大盘”。</p>
</div><p><strong>View Our Latest Stock Report on Skye Bioscience</strong></p>
<div class="lb-trans"><p><strong>查看我们关于 Skye Bioscience 的最新股票报告</strong></p>
</div><h2>Institutional Investors Weigh In On Skye Bioscience</h2>
<div class="lb-trans"><h2>机构投资者对 Skye Bioscience 的看法</h2>
</div><ul>
<li>Don’t Sleep on Skye Bioscience—This Weight Loss Drug Could Soar</li>
</ul>
<div class="lb-trans"><ul>
<li>不要忽视 Skye Bioscience——这款减肥药可能会飙升</li>
</ul>
</div><p>Institutional investors and hedge funds have recently modified their holdings of the stock. Virtu Financial LLC purchased a new stake in shares of Skye Bioscience in the 4th quarter worth about $29,000. Wells Fargo &amp; Company MN lifted its position in shares of Skye Bioscience by 49.0% in the 4th quarter. Wells Fargo &amp; Company MN now owns 11,199 shares of the company's stock worth $32,000 after purchasing an additional 3,684 shares during the period. Two Sigma Advisers LP purchased a new stake in shares of Skye Bioscience in the 4th quarter worth about $32,000. Jane Street Group LLC purchased a new stake in shares of Skye Bioscience in the 3rd quarter worth about $48,000. Finally, Squarepoint Ops LLC purchased a new stake in shares of Skye Bioscience in the 4th quarter worth about $38,000. 21.09% of the stock is owned by hedge funds and other institutional investors.</p>
<div class="lb-trans"><p>机构投资者和对冲基金最近调整了对该股票的持有。Virtu Financial LLC 在第四季度购买了 Skye Bioscience 的新股份，价值约 29,000 美元。Wells Fargo &amp; Company MN 在第四季度将其在 Skye Bioscience 的持仓提高了 49.0%。Wells Fargo &amp; Company MN 现在拥有该公司 11,199 股股票，价值 32,000 美元，此前在此期间又购买了 3,684 股。Two Sigma Advisers LP 在第四季度购买了 Skye Bioscience 的新股份，价值约 32,000 美元。Jane Street Group LLC 在第三季度购买了 Skye Bioscience 的新股份，价值约 48,000 美元。最后，Squarepoint Ops LLC 在第四季度购买了 Skye Bioscience 的新股份，价值约 38,000 美元。21.09% 的股票由对冲基金和其他机构投资者持有。</p>
</div><h2>Skye Bioscience Price Performance</h2>
<div class="lb-trans"><h2>Skye Bioscience 价格表现</h2>
</div><p>Shares of SKYE opened at $2.68 on Friday. The firm has a fifty day simple moving average of $3.02 and a two-hundred day simple moving average of $3.17. Skye Bioscience has a twelve month low of $2.31 and a twelve month high of $19.41.</p>
<div class="lb-trans"><p>周五，SKYE 的股票开盘价为 2.68 美元。该公司的 50 日简单移动平均线为 3.02 美元，200 日简单移动平均线为 3.17 美元。Skye Bioscience 的 12 个月最低价为 2.31 美元，最高价为 19.41 美元。</p>
</div><h2>About Skye Bioscience</h2>
<div class="lb-trans"><h2>关于 Skye Bioscience</h2>
</div><p>(Get Free Report</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><ul>
<li>3 High-Risk, High-Reward Micro-Cap Stocks You Shouldn't Ignore</li>
</ul>
<div class="lb-trans"><ul>
<li>3 只高风险、高回报的微型股你不应忽视</li>
</ul>
</div><p>Skye Bioscience, Inc, a clinical stage pharmaceutical company, discovers, develops, and commercializes cannabinoid-based molecules for the treatment of infectious diseases. The company's lead product candidate is SBI-100 used in the treatment of glaucoma and ocular hypertension. It is also developing SBI-200 to treat and manage various eye diseases, including uveitis, dry eye syndrome, macular degeneration and diabetic retinopathy.</p>
<div class="lb-trans"><p>Skye Bioscience, Inc. 是一家临床阶段的制药公司，发现、开发和商业化基于大麻素的分子用于治疗传染病。该公司的主要产品候选药物是用于治疗青光眼和眼内高压的 SBI-100。它还在开发 SBI-200，以治疗和管理各种眼病，包括葡萄膜炎、干眼症、黄斑变性和糖尿病视网膜病变。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精选故事</h2>
</div><ul>
<li>Five stocks we like better than Skye Bioscience</li>
<li>What is the Hang Seng index?</li>
<li>3 Stocks for Your Watchlist: Unlocking Tomorrow’s Winners Today</li>
<li>Stock Average Calculator</li>
<li>Why Smart Investors Are Watching These 3 Undervalued Stocks</li>
<li>Top Biotech Stocks: Exploring Innovation Opportunities</li>
<li>3 Stocks Breaking Out with More Growth Potential Ahead</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票而非 Skye Bioscience</li>
<li>恒生指数是什么？</li>
<li>3 只值得关注的股票：解锁明天的赢家</li>
<li>股票平均计算器</li>
<li>为什么聪明的投资者在关注这 3 只被低估的股票</li>
<li>顶尖生物科技股票：探索创新机会</li>
<li>3 只突破增长潜力的股票</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9U0tZRQ" alt="" original-src="https://www.marketbeat.com/scripts/RatingsChart.ashx?Prefix=NASDAQ&amp;Symbol=SKYE"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Skye Bioscience Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Skye Bioscience 吗？</h2>
</div><p>Before you consider Skye Bioscience, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑 Skye Bioscience 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Skye Bioscience wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Skye Bioscience 并不在名单上。</p>
</div><p>While Skye Bioscience currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Skye Bioscience 目前在分析师中获得了买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Skye Bioscience, Inc.（纳斯达克股票代码：SKYE）获得券商的平均 “买入” 评级